Compare Grand Pharmaceutical Group Ltd. with Similar Stocks
Dashboard
1
The company has declared Negative results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at HKD 3,224.69 MM
- ROCE(HY) Lowest at 7.41%
- INTEREST COVERAGE RATIO(Q) Lowest at 1,036.74
2
With ROE of 10.19%, it has a Expensive valuation with a 1.49 Price to Book Value
3
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.99%
0%
-26.99%
6 Months
-32.31%
0%
-32.31%
1 Year
-36.82%
0%
-36.82%
2 Years
13.43%
0%
13.43%
3 Years
9.15%
0%
9.15%
4 Years
21.46%
0%
21.46%
5 Years
-19.38%
0%
-19.38%
Grand Pharmaceutical Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.34%
EBIT Growth (5y)
6.17%
EBIT to Interest (avg)
15.55
Debt to EBITDA (avg)
0.35
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.54
Tax Ratio
14.29%
Dividend Payout Ratio
47.69%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.40%
ROE (avg)
14.09%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.49
EV to EBIT
16.28
EV to EBITDA
12.42
EV to Capital Employed
1.42
EV to Sales
2.41
PEG Ratio
NA
Dividend Yield
3.62%
ROCE (Latest)
8.71%
ROE (Latest)
10.19%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
12,283.30
11,644.90
5.48%
Operating Profit (PBDIT) excl Other Income
2,133.00
2,546.40
-16.23%
Interest
162.30
180.20
-9.93%
Exceptional Items
-329.90
603.80
-154.64%
Consolidate Net Profit
1,244.30
2,466.10
-49.54%
Operating Profit Margin (Excl OI)
126.30%
175.40%
-4.91%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 5.48% vs 10.59% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -49.54% vs 30.11% in Dec 2024
About Grand Pharmaceutical Group Ltd. 
Grand Pharmaceutical Group Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






